Theodore Ashburn
Keine laufenden Positionen mehr
Vermögen: 12 518 $ am 31.12.2023
Karriereverlauf von Theodore Ashburn
Ehemalige bekannte Positionen von Theodore Ashburn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ONCORUS, INC. | Comptroller/Controller/Auditor | 01.04.2022 | - |
| Director/Board Member | 01.08.2018 | 06.06.2023 | |
| Chief Executive Officer | 01.08.2018 | 06.06.2023 | |
| Chairman | 06.06.2023 | 28.07.2023 | |
| Director of Finance/CFO | 30.04.2023 | 18.05.2023 | |
| President | 01.08.2018 | 06.06.2023 | |
| MODERNA, INC. | Corporate Officer/Principal | 01.09.2017 | 01.07.2018 |
Dynogen Pharmaceuticals, Inc.
 Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Founder | - | 13.11.2009 |
| Corporate Officer/Principal | - | 13.11.2009 | |
Sanofi Oncology
 Sanofi Oncology Miscellaneous Commercial ServicesCommercial Services Sanofi Oncology provides Salesforce and strategic consulting services. | Corporate Officer/Principal | - | - |
| Leukine | Corporate Officer/Principal | - | - |
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology BrainCells Inc. discovers and develops drugs. The company was founded by Fred H. Gage and Harry F. Hixson, Jr. in 2003 and is headquartered in San Diego, CA. | Founder | - | - |
| DICERNA PHARMACEUTICALS, INC. | Chief Operating Officer | 18.12.2014 | - |
Ausbildung von Theodore Ashburn
| Ball State University (Indiana) | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
| Harvard Medical School | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 11 |
Operativ
| Corporate Officer/Principal | 4 |
| Founder | 2 |
| Doctorate Degree | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ONCORUS, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Health Technology |
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology BrainCells Inc. discovers and develops drugs. The company was founded by Fred H. Gage and Harry F. Hixson, Jr. in 2003 and is headquartered in San Diego, CA. | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Sanofi Oncology
Sanofi Oncology Miscellaneous Commercial ServicesCommercial Services Sanofi Oncology provides Salesforce and strategic consulting services. | Commercial Services |
| Leukine |
- Börse
- Insiders
- Theodore Ashburn
- Erfahrung
